Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402

Toshiyuki Baba, Marimo Sato-Matsushita, Akira Kanamoto, Akihiko Itoh, Naoki Oyaizu, Yusuke Inoue, Yutaka Kawakami, Hideaki Tahara

Research output: Contribution to journalArticle

24 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds